Austrade invites Australian companies with capabilities across clinical research and biotech to join our delegation to Clinical Trials Festival Asia (CTFA 2026), taking place 11–12 March at the Sands Expo & Convention Centre, Singapore.
CTFA is Southeast Asia’s foremost clinical trials conference, offering unparalleled opportunities to connect with regional companies actively seeking trial partners in Australia.
In addition to the main conference program, Austrade will provide:
- A pre-departure briefing from the Southeast Asia Regional Health Team
- Curated business matching with regional stakeholders
- A networking reception hosted at the Australian High Commission, designed to foster deeper engagement and commercial opportunities across Southeast Asia
Why you should participate in CTFA 2026
CTFA is a high-impact platform to:
- Engage with potential clients and collaborators
- Showcase your capabilities to regional sponsors and CROs
- Explore cross-border trial opportunities and market access pathways
- Leverage Austrade’s tailored support and regional health networks
- Places are limited—register your interest now and position your company for regional impact.
Australian Clinical Trials Initiative (ACTI)
The Austrade mission to CTFA 2026 is delivered as part of the broader Australian Clinical Trials Initiative (ACTI) ecosystem. ACTI is a coordinated, national effort to promote Australia as an attractive clinical trials destination. ACTI will encompass 25 events over 18 months, taking place across Europe, North America, the Middle East and Africa (MENA), and Asia-Pacific (APAC).
Go to the ACTI homepage to learn more.
Please note that the expression of interest is NOT yet an official registration to CTFA 2026. Austrade will evaluate all expressions of interest submitted and we will reach out to you to confirm your eligibility, as well as provide information on the next steps for registration and confirmation of participation.
